Chair(s)
Dr Catherine Duggan, FIP, The Netherlands & Ms Susie Stærk Ekstrand, Pharmadanmark, Denmark
Introduction:
Antimicrobial resistance (AMR) is a complex, multifaceted global health crisis that cannot be solved in silos. Tackling it requires coordinated efforts across the healthcare spectrum from frontline health care providers to researchers, policymakers, and the general public. While pharmacists play a key role in appropriate antimicrobial use and consumption, healthcare professionals are central to responsible prescribing, researchers drive innovation through new diagnostics and development of new antimicrobial treatments, policymakers shape the national and global response through regulatory frameworks, and the public are responsible for adhering to the recommendations on how to use antimicrobials.
This plenary session will take the form of a panel discussion, focusing on how healthcare professionals, including pharmacists, researchers, and policymakers, and the public, can collaborate to address and mitigate antimicrobial resistance.
Programme:
| 16:30 – 17:15 | Panel discussion with: |
| Dr Catia Caneiras, ExCo member FIP AMR Commission, Portugal | |
| Mr Rasmus Prior Gjesing, Regional Adviser, World Health Organisation (WHO), Denmark | |
| Prof. Elisabet Nielsen, Platinea, Sweden | |
| Prof. Robert Skov, European Society for Clinical Microbiology and Infections Diseases, Switzerland | |
| 17:15 – 17:30 | Signing ceremony of the call to action: The FIP Copenhagen Declaration on AMR |
| Mr Paul Sinclair, FIP President, Australia & Ms Stine Hasling Mogensen, Chairman of Pharmadanmark, Denmark & Mr Jesper Gulev Larsen, President of the Association of Danish Pharmacies, Denmark
| |
Learning objectives:
1. Describe the multidisciplinary roles of healthcare professionals, researchers, policymakers, and the public in addressing AMR.
2. Identify opportunities for pharmacists to collaborate with other sectors in the One Health approach.
3. Discuss current policy initiatives and research innovations aimed at curbing AMR.
4. Explore strategies to engage the public and promote responsible antimicrobial use.
Take home messages:
Combating AMR requires a united, multi- and interdisciplinary approach—no single profession can solve it alone.
Empowering pharmacists, clinicians, researchers, and communities to work together is essential to preserve antimicrobial effectiveness for future generations.
FIP Development Goals:
Please see below the FIP Development Goals related to the session.
FIP Development Goal 13: Policy Development
FIP Development Goal 17: Antimicrobial Stewardship
FIP Development Goal 21: Sustainability in Pharmacy
